InsidersTradesSigma
Track the 重药控股 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 重药控股 has recorded 2 public disclosures. Market capitalisation: €9.3bn. The latest transaction was disclosed on 19 December 2023 (Purchase). Among the most active insiders: 邱天. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
重药控股 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the distribution of pharmaceutical products and healthcare services.